GlassScriptPhysician profile
Benjamin Michael Robichaux
NPI 1508108911
$1,669.50
in general payments reported to CMS, 2019-2025
11 companies · $714 in 2025
The $714 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $153 · 2021: $36.15 · 2022: $83.15 · 2023: $96.39 · 2024: $38.51 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $698.93 | 2022-2025 | |
| Skeletal Dynamics INC | $432.98 | 2019 | |
| Integra Lifesciences Corporation | $153.35 | 2020 | |
| Wright Medical Technology, INC. | $115.24 | 2019 | |
| Boston Scientific Corporation | $89.24 | 2021-2023 | |
| Alon Medical Technology | $43.30 | 2023 | |
| Sanara Medtech INC. | $37.48 | 2025 | Celleraterx, Biasurge |
| Biocomposites INC | $32.74 | 2025 | Stimulan |
| Acera Surgical, INC. | $27.73 | 2025 | Restrata Wound Matrix |
| Stryker Corporation | $21.89 | 2024 | Hoffmann |
| Abbott Laboratories | $16.62 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Robichaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.